UAE-based healthtech company Pharmedic.ae has won the “Best Homegrown Business Award” at the latest Demo Day for Cohort 11 of the Mohammed Bin Rashid Innovation Fund (MBRIF). The company is developing an AI-powered platform designed to enhance medication safety and precision healthcare.
Quick Facts
- Award: Best Homegrown Business
- Event: MBRIF Cohort 11 Demo Day
- Focus: AI-driven medication guidance
- Founder: Mahra Al Hosani
AI Platform Tackles Clinical Errors
Pharmedic.ae is building a medication guidance platform that integrates AI to reduce critical mistakes in patient care. According to the company, its genome-driven solutions can decrease clinical errors and negative patient outcomes by as much as 35%.
The platform aims to provide healthcare professionals with simplified and reliable decision-support tools, improving the accuracy of care throughout a patient’s treatment journey.
Recognition Within the UAE Ecosystem
The award from MBRIF, a federal initiative to support local innovators, marks another significant milestone for the startup. Pharmedic.ae has also been previously recognized by HH Sheikh Hamdan bin Mohamed Al Maktoum for its technology-driven approach to creating impact in the healthcare sector.
This latest achievement highlights the growing focus on homegrown healthtech solutions within the UAE’s innovation landscape.
About Pharmedic.ae
Pharmedic.ae provides advanced medication decision support tools to improve patient safety. Through its AI-powered and genome-driven solutions, the company focuses on reducing clinical errors and enhancing precision healthcare.
Source: LinkedIn
